Paul Volberding

Paul Volberding, MD is a Professor in the Department of Epidemiology & Biostatistics at the University of California, San Francisco (UCSF). He co-directs the UCSF-Gladstone Center for AIDS Research (CFAR), an NIH-funded program supporting HIV research across UCSF. His work focuses on HIV-associated cancers, global oncology, and international HIV/AIDS initiatives, particularly in East Africa through collaborations with Makerere University’s Infectious Diseases Institute (IDI) in Kampala, Uganda. Dr. Volberding has contributed to clinical guidelines for antiretroviral therapy, HIV prevention strategies, and post-treatment control research. His research spans viral dynamics, immune responses, and public health interventions to reduce HIV transmission and improve care access.

Education and Training: Details not explicitly stated in text, but his roles imply advanced training in oncology and infectious diseases.

Research Interests: Dr. Volberding’s research integrates clinical, epidemiological, and translational approaches to address HIV/AIDS challenges. Key areas include:

• HIV-associated malignancies (e.g., lymphomas, Kaposi’s sarcoma) in resource-limited settings
• Development of global oncology frameworks within cancer centers
• Optimization of antiretroviral therapy and treatment interruption studies
• Post-treatment HIV controllers and viral remission mechanisms
• Public health strategies for HIV prevention, including condom distribution and PrEP
• Healthcare system impacts of HIV and co-infections (e.g., hepatitis C)

Grants and Collaborations: Leads CFAR’s multidisciplinary research program, supporting pilot grants and international collaborations. Active in training Ugandan scientists through the IDI.

Labs/Teams: Co-directs the UCSF-Gladstone CFAR and collaborates with global networks like the CHAMP study group.